923 related articles for article (PubMed ID: 26155316)
1. Current Approaches for Improving Intratumoral Accumulation and Distribution of Nanomedicines.
Durymanov MO; Rosenkranz AA; Sobolev AS
Theranostics; 2015; 5(9):1007-20. PubMed ID: 26155316
[TBL] [Abstract][Full Text] [Related]
2. Factors affecting toxicity and efficacy of polymeric nanomedicines.
Igarashi E
Toxicol Appl Pharmacol; 2008 May; 229(1):121-34. PubMed ID: 18355886
[TBL] [Abstract][Full Text] [Related]
3. Imaging-assisted anticancer nanotherapy.
Dasgupta A; Biancacci I; Kiessling F; Lammers T
Theranostics; 2020; 10(3):956-967. PubMed ID: 31938045
[TBL] [Abstract][Full Text] [Related]
4. Tumor-targeted nanomedicines for cancer theranostics.
Arranja AG; Pathak V; Lammers T; Shi Y
Pharmacol Res; 2017 Jan; 115():87-95. PubMed ID: 27865762
[TBL] [Abstract][Full Text] [Related]
5. Extravasation of polymeric nanomedicines across tumor vasculature.
Danquah MK; Zhang XA; Mahato RI
Adv Drug Deliv Rev; 2011 Jul; 63(8):623-39. PubMed ID: 21144874
[TBL] [Abstract][Full Text] [Related]
6. Nanomedicines for the treatment of hematological malignancies.
Deshantri AK; Varela Moreira A; Ecker V; Mandhane SN; Schiffelers RM; Buchner M; Fens MHAM
J Control Release; 2018 Oct; 287():194-215. PubMed ID: 30165140
[TBL] [Abstract][Full Text] [Related]
7. Hyperthermia approaches for enhanced delivery of nanomedicines to solid tumors.
Frazier N; Ghandehari H
Biotechnol Bioeng; 2015 Oct; 112(10):1967-83. PubMed ID: 25995079
[TBL] [Abstract][Full Text] [Related]
8. Targeting Brain Tumors with Nanomedicines: Overcoming Blood Brain Barrier Challenges.
Khaitan D; Reddy PL; Ningaraj N
Curr Clin Pharmacol; 2018; 13(2):110-119. PubMed ID: 29651960
[TBL] [Abstract][Full Text] [Related]
9. Nanomedicines based drug delivery systems for anti-cancer targeting and treatment.
Jain V; Jain S; Mahajan SC
Curr Drug Deliv; 2015; 12(2):177-91. PubMed ID: 25146439
[TBL] [Abstract][Full Text] [Related]
10. Modulating the Tumor Microenvironment to Enhance Tumor Nanomedicine Delivery.
Zhang B; Hu Y; Pang Z
Front Pharmacol; 2017; 8():952. PubMed ID: 29311946
[TBL] [Abstract][Full Text] [Related]
11. Paclitaxel-loaded micelles enhance transvascular permeability and retention of nanomedicines in tumors.
Danhier F; Danhier P; De Saedeleer CJ; Fruytier AC; Schleich N; des Rieux A; Sonveaux P; Gallez B; Préat V
Int J Pharm; 2015 Feb; 479(2):399-407. PubMed ID: 25578367
[TBL] [Abstract][Full Text] [Related]
12. The Clinical Translation of Organic Nanomaterials for Cancer Therapy: A Focus on Polymeric Nanoparticles, Micelles, Liposomes and Exosomes.
Palazzolo S; Bayda S; Hadla M; Caligiuri I; Corona G; Toffoli G; Rizzolio F
Curr Med Chem; 2018; 25(34):4224-4268. PubMed ID: 28875844
[TBL] [Abstract][Full Text] [Related]
13. Unraveling the role of Intralipid in suppressing off-target delivery and augmenting the therapeutic effects of anticancer nanomedicines.
Islam R; Gao S; Islam W; Šubr V; Zhou JR; Yokomizo K; Etrych T; Maeda H; Fang J
Acta Biomater; 2021 May; 126():372-383. PubMed ID: 33774199
[TBL] [Abstract][Full Text] [Related]
14. Tumor Penetrating Theranostic Nanoparticles for Enhancement of Targeted and Image-guided Drug Delivery into Peritoneal Tumors following Intraperitoneal Delivery.
Gao N; Bozeman EN; Qian W; Wang L; Chen H; Lipowska M; Staley CA; Wang YA; Mao H; Yang L
Theranostics; 2017; 7(6):1689-1704. PubMed ID: 28529645
[TBL] [Abstract][Full Text] [Related]
15. Factors Influencing the Delivery Efficiency of Cancer Nanomedicines.
Ullah R; Wazir J; Khan FU; Diallo MT; Ihsan AU; Mikrani R; Aquib M; Zhou X
AAPS PharmSciTech; 2020 May; 21(4):132. PubMed ID: 32409932
[TBL] [Abstract][Full Text] [Related]
16. Enhancing Tumor Penetration of Nanomedicines.
Sun Q; Ojha T; Kiessling F; Lammers T; Shi Y
Biomacromolecules; 2017 May; 18(5):1449-1459. PubMed ID: 28328191
[TBL] [Abstract][Full Text] [Related]
17. The spatiotemporal journey of nanomedicines in solid tumors on their therapeutic efficacy.
Qin M; Xia H; Xu W; Chen B; Wang Y
Adv Drug Deliv Rev; 2023 Dec; 203():115137. PubMed ID: 37949414
[TBL] [Abstract][Full Text] [Related]
18. [The development of novel tumor targeting delivery strategy].
Gao HL; Jiang XG
Yao Xue Xue Bao; 2016 Feb; 51(2):272-80. PubMed ID: 29856581
[TBL] [Abstract][Full Text] [Related]
19. Nanomedicines for advanced cancer treatments: Transitioning towards responsive systems.
van Elk M; Murphy BP; Eufrásio-da-Silva T; O'Reilly DP; Vermonden T; Hennink WE; Duffy GP; Ruiz-Hernández E
Int J Pharm; 2016 Dec; 515(1-2):132-164. PubMed ID: 27725268
[TBL] [Abstract][Full Text] [Related]
20. Effect of biophysical properties of tumor extracellular matrix on intratumoral fate of nanoparticles: Implications on the design of nanomedicine.
Tian Y; Cheng T; Sun F; Zhou Y; Yuan C; Guo Z; Wang Z
Adv Colloid Interface Sci; 2024 Apr; 326():103124. PubMed ID: 38461766
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]